Rockefeller Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.4K | Sell |
|
|||||
|
2025
Q2 | $229K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $201K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $43K | Hold |
|
|||||
|
2022
Q3 | $47K | Hold |
|
|||||
|
2022
Q2 | $40K | Sell |
|
|||||
|
2022
Q1 | $62K | Buy |
|
|||||
|
2021
Q4 | $52K | Hold |
|
|||||
|
2021
Q3 | $54K | Hold |
|
|||||
|
2021
Q2 | $60K | Hold |
|
|||||
|
2021
Q1 | $38K | Buy |
|
|||||
|
2020
Q4 | $24K | Hold |
|
|||||
|
2020
Q3 | $11K | Hold |
|
|||||
|
2020
Q2 | $16K | Hold |
|
|||||
|
2020
Q1 | $7K | Buy |
|